Home
Categories
EXPLORE
Society & Culture
Music
Education
True Crime
History
Religion & Spirituality
Comedy
About Us
Contact Us
Copyright
© 2024 PodJoint
00:00 / 00:00
Sign in

or

Don't have an account?
Sign up
Forgot password
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/92/64/ae/9264aec2-1bdc-aea3-4b83-3226c5aaadb5/mza_14365421335624065445.jpg/600x600bb.jpg
New Retina Radio by Eyetube
Retina Today
220 episodes
2 days ago
New Retina Radio is a place to hear stories about retina that are told nowhere else.
Show more...
Science
Technology
RSS
All content for New Retina Radio by Eyetube is the property of Retina Today and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
New Retina Radio is a place to hear stories about retina that are told nowhere else.
Show more...
Science
Technology
https://is1-ssl.mzstatic.com/image/thumb/Podcasts122/v4/92/64/ae/9264aec2-1bdc-aea3-4b83-3226c5aaadb5/mza_14365421335624065445.jpg/600x600bb.jpg
AAO '25: Dry AMD Pipeline and Oral Treatment for Stargardt Disease
New Retina Radio by Eyetube
27 minutes
1 week ago
AAO '25: Dry AMD Pipeline and Oral Treatment for Stargardt Disease
The dry AMD pipeline is packed. Join New Retina Radio as we break it down with Peter Kaiser, MD, whose podium presentation at AAO 2025 offered a survey of developmental projects in dry AMD. What should we look forward to? And Michel Michaelides, MD, shares details from the DRAGON study, which examined the safety and efficacy of tinlarebant (Belite Bio) for the treatment of Stargardt disease. Could a once-daily oral tablet lead to positive outcomes for patients? Listen to the episode to learn more.
New Retina Radio by Eyetube
New Retina Radio is a place to hear stories about retina that are told nowhere else.